نظرة سريعة
Renaming Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) aims to improve understanding and treatment of the hormonal disorder affecting over 170 million women globally, including symptoms like irregular periods, excess hair growth, and infertility risks.
ملخص مُنشأ بالذكاء الاصطناعي
حجم الخط
Renaming Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) aims to improve understanding and treatment of the hormonal disorder affecting over 170 million women globally, including symptoms like irregular periods, excess hair growth, and infertility risks.
مواضيع ذات صلة
This article was originally published by BBC News.
